Pfizer: Pain trials

The registry lists 74 Pain studies with Pfizer as lead sponsor. 0 are open to participants now and 34 have results posted.

Phase 1 15Phase 2 20Phase 3 28Phase 4 7No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Trial for Treatment Refractory Trigeminal NeuralgiaTerminatedNCT03941834Phase 2Results posted
• Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC ConsumersTerminatedNCT03722238Phase 3Results posted
• A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental PainCompletedNCT02912650Phase 3Results posted
• A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/CaffeineCompletedNCT02863575Phase 3Results posted
• A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental PainCompletedNCT02837952Phase 3Results posted
• Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.CompletedNCT02709486Phase 3Results posted
• Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With PainTerminatedNCT02680847Phase 4Results posted
• Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With PainTerminatedNCT02101554Phase 4Results posted
• Topical Ibuprofen for Delayed Onset Mulscle SorenessCompletedNCT01794923Phase 3Results posted
• Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental PainCompletedNCT01559259Phase 2Results posted
• Efficacy Of PF-05089771 In Treating Postoperative Dental PainCompletedNCT01529346Phase 2Results posted
• Efficacy Of Pf-04531083 In Treating Post-Surgical Dental PainTerminatedNCT01512160Phase 2Results posted
• Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer PainCompletedNCT01428583Phase 3Results posted
• Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 MonthsCompletedNCT01378988Phase 2Results posted
• Ibuprofen Sodium Tension Headache StudyCompletedNCT01362491Phase 3Results posted
• Multiple Dose Dental Pain Study Of Ibuprofen Extended ReleaseCompletedNCT01266161Phase 3Results posted
• Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental PainCompletedNCT01216163Phase 3Results posted
• Conversion to Embeda With Rescue TrialTerminatedNCT01179191Phase 4Results posted
• A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The KneeTerminatedNCT01147458Phase 2Results posted
• Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental PainCompletedNCT01098747Phase 3Results posted
• Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging StudyTerminatedNCT01089725Phase 3Results posted
• Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type HeadacheCompletedNCT01077973Phase 3Results posted
• A Study To Evaluate Methods To Evaluate Back PainCompletedNCT01045993Not applicableResults posted
• Tanezumab In Osteoarthritis Of The Hip Or KneeTerminatedNCT00985621Phase 3Results posted
• Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental PainCompletedNCT00913627Phase 2Results posted
• Tanezumab In Osteoarthritis Of The Knee (2)CompletedNCT00830063Phase 3Results posted
• A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With EndometriosisTerminatedNCT00784693Phase 2Results posted
• Study Comparing the Efficacy of Two Ibuprofen FormulationsCompletedNCT00740857Phase 4Results posted
• Tanezumab in Osteoarthritis of the KneeCompletedNCT00733902Phase 3Results posted
• Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking AvinzaCompletedNCT00640042Phase 4Results posted
• Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal ColicCompletedNCT00553605Phase 4Results posted
• A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or KneeCompletedNCT00420992Phase 3Results posted
• Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant PainCompletedNCT00415597Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral NeuropathyTerminatedNCT00283842Phase 3Results posted
• Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain EndpointsCompletedNCT02238717Phase 1
• Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in FinlandTerminatedNCT01787565
• RIPT of Ibuprofen Topical GelCompletedNCT01787448Phase 1
• Ibuprofen 5% Topical Gel CIPTCompletedNCT01771822Phase 1
• A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed StateCompletedNCT01706796Phase 1
• A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted StateCompletedNCT01690351Phase 1
• A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340CompletedNCT01601834Phase 1
• A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed StateCompletedNCT01563497Phase 1
• Pharmacokinetics Study of ALO-02 and OxyContinCompletedNCT01557257Phase 1
• A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The KneeCompletedNCT01529671Phase 1
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women VolunteersCompletedNCT01511497Phase 1
• A Study of ARRY-371797 in Patients With Osteoarthritis of the KneeCompletedNCT01366014Phase 2
• The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.CompletedNCT01365637Phase 1
• A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy VolunteersCompletedNCT01259882Phase 1
• Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is InjectedCompletedNCT01030640Phase 1
• To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male SubjectsCompletedNCT00992316
• Relative Bioavailability and Food Effect StudyWithdrawnNCT00827515Phase 1
• Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic NeuralgiaTerminatedNCT00809679Phase 2
• A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male SubjectsCompletedNCT00747058Phase 1
• Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic SurgeryCompletedNCT00709436Phase 3
• Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy SurgeryCompletedNCT00683137Phase 3
• A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained AnkleCompletedNCT00671320Phase 4
• A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery PainCompletedNCT00661635Phase 3
• A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal SurgeryTerminatedNCT00651300Phase 3
• Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) ReconstructionCompletedNCT00650039Phase 3
• A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass SurgeryCompletedNCT00636064Phase 3
• Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental PainCompletedNCT00631111Phase 3
• A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles OutbreakWithdrawnNCT00506610Phase 2
• Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer PatientsTerminatedNCT00492388Phase 3
• A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The KneeTerminatedNCT00396955Phase 2
• A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With FibromyalgiaCompletedNCT00357825Phase 2
• [S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.TerminatedNCT00354094Phase 2
• A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.TerminatedNCT00353808Phase 2
• [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.TerminatedNCT00348894Phase 2
• [S,S]-Reboxetine Add-On TrialTerminatedNCT00334685Phase 2
• [S,S]-Reboxetine Dose-Range Finding TrialCompletedNCT00288652Phase 2
• Study Evaluating Rhapsody Registry in Patients With Depression and AnxietyCompletedNCT00241397
• Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic NeuralgiaTerminatedNCT00159640Phase 2
• Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment FailuresCompletedNCT00143442Phase 2
• Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.CompletedNCT00141362Phase 3